{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:26:28Z","timestamp":1789748788392,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T00:00:00Z","timestamp":1492646400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T00:00:00Z","timestamp":1492646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK053904"],"award-info":[{"award-number":["DK053904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA09300"],"award-info":[{"award-number":["CA09300"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00198-017-4032-1","type":"journal-article","created":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T09:09:13Z","timestamp":1492679353000},"page":"2321-2333","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The skeletal impact of the chemotherapeutic agent etoposide"],"prefix":"10.1007","volume":"28","author":[{"given":"A. J.","family":"Koh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. P.","family":"Sinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Entezami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. K.","family":"McCauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,20]]},"reference":[{"key":"4032_CR1","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.281.5381.1317","volume":"281","author":"G Evan","year":"1998","unstructured":"Evan G, Littlewood T (1998) A matter of life and cell death. Science 281:1317\u20131322","journal-title":"Science"},{"key":"4032_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrc3055","volume":"11","author":"KN Weilbaecher","year":"2011","unstructured":"Weilbaecher KN, Guise TA, McCauley LK (2011) Cancer to bone: a fatal attraction. Nat Rev Cancer 11:411\u2013425","journal-title":"Nat Rev Cancer"},{"key":"4032_CR3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrc.2016.25","volume":"16","author":"PS Steeg","year":"2016","unstructured":"Steeg PS (2016) Targeting metastasis. Nat Rev Cancer 16:201\u2013218","journal-title":"Nat Rev Cancer"},{"key":"4032_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2174\/1568011054222364","volume":"5","author":"EL Baldwin","year":"2005","unstructured":"Baldwin EL, Osheroff N (2005) Etoposide, topoisomerase II and cancer. Curr Med Chem Anticancer Agents 5:363\u2013372","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"4032_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1634\/theoncologist.2011-0177","volume":"17","author":"A Colpo","year":"2012","unstructured":"Colpo A, Hochberg E, Chen YB (2012) Current status of autologous stem cell transplantation in relapsed and refractory Hodgkin\u2019s lymphoma. Oncologist 17:80\u201390","journal-title":"Oncologist"},{"key":"4032_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.chembiol.2010.04.012","volume":"17","author":"Y Pommier","year":"2010","unstructured":"Pommier Y, Leo E, Zhang H, Marchand C (2010) DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol 17:421\u2013433","journal-title":"Chem Biol"},{"key":"4032_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2006.11.005","volume":"252","author":"A Montecucco","year":"2007","unstructured":"Montecucco A, Biamonti G (2007) Cellular response to etoposide treatment. Cancer Lett 252:9\u201318","journal-title":"Cancer Lett"},{"key":"4032_CR8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11914-013-0165-0","volume":"11","author":"CL Wilson","year":"2013","unstructured":"Wilson CL, Ness KK (2013) Bone mineral density deficits and fractures in survivors of childhood cancer. Curr Osteoporosis Rep 11:329\u2013337","journal-title":"Curr Osteoporosis Rep"},{"key":"4032_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3109\/08880018.2015.1048912","volume":"32","author":"MM Sch\u00fcndeln","year":"2015","unstructured":"Sch\u00fcndeln MM, Hauffa PK, Bauer JJ, Temming P, Sauerwein W, Biewald E, Bornfeld N, Hauffa BP, Grasemann C (2015) Pediatric survivors of retinoblastoma are at risk for altered bone metabolism after chemotherapy treatment early in life. Pediatr Hematol Oncol 32:455\u2013466","journal-title":"Pediatr Hematol Oncol"},{"key":"4032_CR10","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1001\/jama.2013.6296","volume":"309","author":"MM Hudson","year":"2013","unstructured":"Hudson MM, Ness KK, Gurney JG, Mulrooney DA, Chemaitilly W, Krull KR, Green DM, Armstrong GT, Nottage KA, Jones KE, Sklar CA, Srivastava DK, Robison LL (2013) Clinical ascertainment of health outcomes among adults treated for childhood cancer. J Am Med Assoc 309:2371\u20132381","journal-title":"J Am Med Assoc"},{"key":"4032_CR11","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1097\/TP.0b013e3181d84c8e","volume":"89","author":"AD Petropoulou","year":"2010","unstructured":"Petropoulou AD, Porcher R, Herr AL, Devergie A, Brentano TF, Ribaud P, Pinto FO, Rocha V, Peffault de Latour R, Orcel P, Socie G, Robin M (2010) Prospective assessment of bone turnover and clinical bone diseases after allogeneic hematopoietic stem-cell transplantation. Transplantation 89:1354\u20131361","journal-title":"Transplantation"},{"key":"4032_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/sj.bmt.1703149","volume":"28","author":"AD Schimmer","year":"2001","unstructured":"Schimmer AD, Mah K, Bordeleau L, Cheung A, Ali V, Falconer M, Trus M, Keating A (2001) Decreased bone mineral density is common after autologous blood or marrow transplantation. Bone Marrow Transplant 28:387\u2013391","journal-title":"Bone Marrow Transplant"},{"key":"4032_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1399-0012.2011.01527.x","volume":"26","author":"S Ganguly","year":"2012","unstructured":"Ganguly S, Divine CL, Aljitawi OS, Abhyankar S, McGuirk JP, Graves L (2012) Prophylactic use of zoledronic acid to prevent early bone loss is safe and feasible in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation. Clin Transpl 26:447\u2013453","journal-title":"Clin Transpl"},{"key":"4032_CR14","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.bone.2005.02.015","volume":"36","author":"GJ Pettway","year":"2005","unstructured":"Pettway GJ, Schneider A, Koh AJ, Widjaja E, Morris MD, Meganck JA, Goldstein SA, McCauley LK (2005) Anabolic actions of PTH (1-34): use of a novel tissue engineering model to investigate temporal effects on bone. Bone 36:959\u2013970","journal-title":"Bone"},{"key":"4032_CR15","doi-asserted-by":"publisher","first-page":"6814","DOI":"10.1074\/jbc.M112.393363","volume":"288","author":"SW Cho","year":"2013","unstructured":"Cho SW, Pirih FQ, Koh AJ, Michalski M, Eber MR, Ritchie K, Sinder BP, Oh S, Al-Dujaili SA, Lee J, Kozloff K, Danciu T, Wronski TJ, McCauley LK (2013) The soluble interleukin-6 receptor is a mediator of hematopoietic and skeletal actions of parathyroid hormone. J Biol Chem 288:6814\u20136825","journal-title":"J Biol Chem"},{"key":"4032_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1084\/jem.174.4.827","volume":"174","author":"SS Rabinowitz","year":"1991","unstructured":"Rabinowitz SS, Gordon S (1991) Macrosialin, a macrophage-restricted membrane sialoprotein differentially glycosylated in response to inflammatory stimuli. J Exp Med 174:827\u2013836","journal-title":"J Exp Med"},{"key":"4032_CR17","doi-asserted-by":"publisher","first-page":"14833","DOI":"10.1073\/pnas.93.25.14833","volume":"93","author":"MP Ramprasad","year":"1996","unstructured":"Ramprasad MP, Terpstra V, Kondratenko N, Quehenberger O, Steinberg D (1996) Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci U S A 93:14833\u201314838","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4032_CR18","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1084\/jem.20091046","volume":"206","author":"S Morikawa","year":"2009","unstructured":"Morikawa S, Mabuchi Y, Kubota Y, Nagai Y, Niibe K, Hiratsu E, Suzuki S, Miyauchi-Hara C, Nagoshi N, Sunabori T, Shimmura S, Miyawaki A, Nakagawa T, Suda T, Okano H, Matsuzaki Y (2009) Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med 206:2483\u20132496","journal-title":"J Exp Med"},{"key":"4032_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.stem.2014.06.008","volume":"15","author":"B Zhou","year":"2014","unstructured":"Zhou B, Yue R, Murphy MM, Peyer J, Morrison SJ (2014) Leptin receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell 15:154\u2013168","journal-title":"Cell Stem Cell"},{"key":"4032_CR20","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1126\/science.283.5403.845","volume":"5","author":"A Peled","year":"1999","unstructured":"Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, Byk T, Nagler A, Ben-Hur H, Many A, Shultz L, Lider O, Alon R, Zipori D, Lapidot T (1999) Dependence of human stem cell engraftment and repopulation of NOD\/SCID mice on CXCR4. Science 5:845\u2013848","journal-title":"Science"},{"key":"4032_CR21","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, Jan de Beur S, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R (2014) Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359\u20132381","journal-title":"Osteoporos Int"},{"key":"4032_CR22","first-page":"95","volume":"14","author":"A Montecucco","year":"2015","unstructured":"Montecucco A, Zanetta F, Biamonti G (2015) Molecular mechanisms of etoposide. EXCI J 14:95\u2013108","journal-title":"EXCI J"},{"key":"4032_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-3-642-38007-5_8","volume":"159","author":"B Orlikova","year":"2014","unstructured":"Orlikova B, Legrand N, Panning J, Dicato M, Diederich M (2014) Anti-inflammatory and anticancer drugs from nature. Cancer Treat Res 159:123\u2013143","journal-title":"Cancer Treat Res"},{"key":"4032_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10753-007-9049-8","volume":"31","author":"M Remichkova","year":"2008","unstructured":"Remichkova M, Yordanov M, Dimitrova P (2008) Etoposide attenuates zymosan-induced shock in mice. Inflammation 31:57\u201364","journal-title":"Inflammation"},{"key":"4032_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.canlet.2016.02.007","volume":"374","author":"NH Nicolay","year":"2016","unstructured":"Nicolay NH, Ruhle A, Lopez Perez R, Trinh T, Sisombath S, Weber KJ, Schmezer P, Ho AD, Debus J, Saffrich R, Huber PE (2016) Mesenchymal stem cells exhibit resistance to topoisomerase inhibition. Cancer Lett 374:75\u201384","journal-title":"Cancer Lett"},{"key":"4032_CR26","doi-asserted-by":"publisher","first-page":"e30758","DOI":"10.1371\/journal.pone.0030758","volume":"7","author":"SL Rellick","year":"2016","unstructured":"Rellick SL, O\u2019Leary H, Piktel D, Walton C, Fortney JE, Akers SM, Martin KH, Denvir J, Boskovic G, Primerano DA, Vos J, Bailey N, Gencheva M, Gibson LF (2016) Bone marrow osteoblast damage by chemotherapeutic agents. PLoS One 7:e30758","journal-title":"PLoS One"},{"key":"4032_CR27","first-page":"327","volume":"56","author":"U Cegiela","year":"2004","unstructured":"Cegiela U, Folwarczna J, Pytlik M, Janiec W (2004) Effect of etoposide on the processes of osseous tissue remodeling in rats. Pol J Pharmacol 56:327\u2013336","journal-title":"Pol J Pharmacol"},{"key":"4032_CR28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4161\/cbt.6.2.3576","volume":"6","author":"CJ Xian","year":"2007","unstructured":"Xian CJ, Cool JC, van Gangelen J, Foster BK, Howarth GS (2007) Effects of etoposide and cyclophosphamide acute chemotherapy on growth plate and metaphyseal bone in rats. Cancer Biol Ther 6:170\u2013177","journal-title":"Cancer Biol Ther"},{"key":"4032_CR29","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/nature02040","volume":"425","author":"LM Calvi","year":"2003","unstructured":"Calvi LM, Adams GB, Welbrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT (2003) Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425:841\u2013846","journal-title":"Nature"},{"key":"4032_CR30","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1182\/blood-2004-06-2480","volume":"105","author":"RS Taichman","year":"2005","unstructured":"Taichman RS (2005) Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem cell niche. Blood 105:2631\u20132639","journal-title":"Blood"},{"key":"4032_CR31","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.4049\/jimmunol.181.2.1232","volume":"181","author":"MK Chang","year":"2008","unstructured":"Chang MK, Raggatt LJ, Alexander KA, Kuliwaba JS, Fazzalari NL, Schroeder K, Maylin ER, Ripoll VM, Hume DA, Pettit AR (2008) Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. J Immunol 181:1232\u20131244","journal-title":"J Immunol"},{"key":"4032_CR32","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1002\/jbmr.2735","volume":"30","author":"BP Sinder","year":"2015","unstructured":"Sinder BP, Pettit AR, McCauley LK (2015) Macrophages: their emerging roles in bone. J Bone Miner Res 30:2140\u20132149","journal-title":"J Bone Miner Res"},{"key":"4032_CR33","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/jbmr.354","volume":"26","author":"KA Alexander","year":"2011","unstructured":"Alexander KA, Chang MK, Maylin ER, Kohler T, M\u00fcller R, Wu AC, van Rooijen N, Sweet MJ, Hume DA, Raggatt LJ, Pettit AR (2011) Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. J Bone Miner Res 26:1517\u20131532","journal-title":"J Bone Miner Res"},{"key":"4032_CR34","doi-asserted-by":"publisher","first-page":"24560","DOI":"10.1074\/jbc.M114.571620","volume":"289","author":"FN Soki","year":"2014","unstructured":"Soki FN, Koh AJ, Jones JD, Kim YW, Dai J, Keller ET, Pienta KJ, Atabai K, Roca H, McCauley LK (2014) Polarization of prostate cancer-associated macrophages is induced by milk fat globule-EGF factor 8 (MFG-E8)-mediated efferocytosis. J Biol Chem 289:24560\u201324572","journal-title":"J Biol Chem"},{"key":"4032_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2011.00057","volume":"2","author":"D Korns","year":"2011","unstructured":"Korns D, Frasch SC, Fernandez-Boyanapalli R, Henson PM, Bratton DL (2011) Modulation of macrophage efferocytosis in inflammation. Front Immunol 2:1\u201310","journal-title":"Front Immunol"},{"key":"4032_CR36","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1002\/jcb.25567","volume":"117","author":"MN Michalski","year":"2016","unstructured":"Michalski MN, Koh AJ, Weidner S, Roca H, McCauley LK (2016) Modulation of osteoblastic cell efferocytosis by bone marrow macrophages. J Cell Biochem 117:2697\u20132706","journal-title":"J Cell Biochem"},{"key":"4032_CR37","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1210\/en.2011-1515","volume":"152","author":"AJ Koh","year":"2011","unstructured":"Koh AJ, Novince CM, Li X, Wang T, Taichman RS, McCauley LK (2011) An irradiation-altered bone marrow microenvironment impacts anabolic actions of PTH. Endocrinology 152:4525\u20134536","journal-title":"Endocrinology"},{"key":"4032_CR38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s00223-007-9091-4","volume":"82","author":"JP Rissanen","year":"2008","unstructured":"Rissanen JP, Suominen MI, Peng Z, Halleen JM (2008) Secreted tartrate-resistant acid phosphatase 5b is a marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model. Calcif Tissue Int 82:108\u2013115","journal-title":"Calcif Tissue Int"},{"key":"4032_CR39","doi-asserted-by":"publisher","first-page":"28164","DOI":"10.1074\/jbc.M110.101964","volume":"285","author":"DD Pierroz","year":"2010","unstructured":"Pierroz DD, Bonnet N, Baldock PA, Ominsky MS, Stolina M, Kostenuik PJ, Ferrari SL (2010) Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL. J Biol Chem 285:28164\u201328173","journal-title":"J Biol Chem"},{"key":"4032_CR40","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3109\/08916934.2012.719950","volume":"45","author":"U Harre","year":"2012","unstructured":"Harre U, Keppeler H, Ipseiz N, Derer A, Poller K, Aigner M, Schett G, Herrmann M, Lauber K (2012) Moonlighting osteoclasts as undertakers of apoptotic cells. Autoimmunity 45:612\u2013619","journal-title":"Autoimmunity"},{"key":"4032_CR41","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1007\/s00198-013-2530-3","volume":"24","author":"R Rizzoli","year":"2013","unstructured":"Rizzoli R, Body JJ, Brandi ML, Cannata-Andia J, Chappard D, El Maghraoui A, Gluer CC, Kendler DL, Napoli N, Papaioannou A, Pierroz DS, Rahme M, Van Poznak CH, de Villiers TJ, El Hajj Fuleihan G (2013) Cancer-associated bone disease. Osteoporos Int 24:2929\u20132953","journal-title":"Osteoporos Int"},{"key":"4032_CR42","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/jbmr.2415","volume":"30","author":"JM Quach","year":"2015","unstructured":"Quach JM, Askmyr M, Jovic T, Baker EK, Walsh NC, Harrison SJ, Neeson P, Ritchie D, Ebeling PR, Purton LE (2015) Myelosuppressive therapies significantly increase pro-inflammatory cytokines and directly cause bone loss. J Bone Miner Res 30:886\u2013897","journal-title":"J Bone Miner Res"},{"key":"4032_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/jcb.24301","volume":"114","author":"FN Soki","year":"2013","unstructured":"Soki FN, Li X, Berry JE, Koh AJ, Sinder BP, Qian X, Kozloff KM, Taichman RS, McCauley LK (2013) The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell niches. J Cell Biochem 114:67\u201378","journal-title":"J Cell Biochem"},{"key":"4032_CR44","doi-asserted-by":"publisher","first-page":"6213s","DOI":"10.1158\/1078-0432.CCR-06-1007","volume":"20","author":"TA Guise","year":"2006","unstructured":"Guise TA, Mohammad KS, Clines G, Stebbens EG, Wong DH, Higgens LS, Vessella RL, Corey E, Padalecki SS, Suva L, Chirgwin JM (2006) Basic mechanisms responsible for osteolytic and osteoblastic bone metastases. Clin Cancer Res 20:6213s\u20136216s","journal-title":"Clin Cancer Res"},{"key":"4032_CR45","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1158\/1078-0432.CCR-13-1246","volume":"20","author":"PD Ottewell","year":"2014","unstructured":"Ottewell PD, Wang N, Brown HK, Reeves KJ, Fowles CA, Croucher PI, Eaton CL, Holen I (2014) Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivo. Clin Cancer Res 20:2922\u20132932","journal-title":"Clin Cancer Res"},{"key":"4032_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jbmr.2405","volume":"30","author":"AA Khan","year":"2015","unstructured":"Khan AA, Morrison A, Hanley DA, Felsenberg D, LK MC, O\u2019Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts N, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, Al Dabagh R, Davison KS, Kendler DL, Sandor GK, Josse RG, Bhandari M, El Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston JE (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30:3\u201323","journal-title":"J Bone Miner Res"},{"key":"4032_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bone.2014.12.011","volume":"73","author":"F Lezot","year":"2015","unstructured":"Lezot F, Chesneau J, Navet B, Gobin B, Amiaud J, Choi Y, Yagita H, Castaneda B, Berdal A, Mueller CG, Redini F, Heynamm D (2015) Preclinical evidence of potential craniofacial adverse effect of zoledronic acid in pediatric patients with bone malignancies. Bone 73:51\u201359","journal-title":"Bone"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-017-4032-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-017-4032-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-017-4032-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T07:40:05Z","timestamp":1589442005000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-017-4032-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,20]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["4032"],"URL":"https:\/\/doi.org\/10.1007\/s00198-017-4032-1","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,20]]},"assertion":[{"value":"5 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were performed with the approval of the University of Michigan Committee for the Use and Care of Animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}